Published by Josh White on 18th January 2021
(Sharecast News) - Clinical-stage biopharmaceuticals company Faron Pharmaceuticals announced on Monday that the US Department of Defense (DoD) has selected the 'HIBISCUS' study to receive $6.1m (£4.5m) of funding under the Coronavirus Aid, Relief, and Economic Security (CARES) Act.
URL: http://www.digitallook.com/dl/news/story/31584321/...